Molecular and functional changes in GABAergic transmission during epileptogenesis in a rat model of post-traumatic epilepsy
Traumatic brain injury (TBI) is one of the leading causes of structural epilepsy. Our objective was to investigate the molecular and functional dysregulation of GABAergic neurotransmission during a wide time window from acute to chronic phases of epileptogenesis after TBI. Perilesional and thalamic tissues sampled from a clinically relevant animal model of post-traumatic epilepsy induced by lateral fluid-percussion injury were investigated using in situ hybridization, immunohistochemistry and RNA sequencing. For functional analysis, we utilized a membrane microtransplantation technique in Xenopus oocytes in order to overcome the technical difficulties that would stem from recording directly from highly damaged lesional and perilesional brain tissues. Already at 6 to 24 h post-TBI we found a dysregulation in the expression of GABA<sub>A</sub>R β3- and δ-subunits, which persisted for up to 4 months. Further, gene set enrichment analysis revealed a negative enrichment of GABA receptor signaling in the perilesional cortex and ipsilateral thalamus. These changes occurred in parallel to the dysregulation of the two main cation-chloride cotransporter genes (Slc12a2 and Slc12a5) both in the perilesional cortex and the ipsilateral thalamus. Our functional analysis revealed that the GABA current reversal potential (E<sub>GABA</sub>) was shifted towards more depolarized values in the perilesional cortex and ipsilateral thalamus. Our data demonstrate a rapid onset and long-lasting duration of GABAergic dysfunction after TBI and support the hypothesis that an early treatment with agents modulating the GABAergic transmission in the thalamo-cortical-thalamic circuitry may suppress early seizures as well as prevent or slow down epileptogenesis after TBI.
Authors
- Gabriele Ruffolo (ORCID: https://orcid.org/0000-0002-6554-5496)
- Eleonora Palma (ORCID: https://orcid.org/0000-0001-6026-927X)
- Cristina Roseti (ORCID: https://orcid.org/0000-0002-9863-0371)
- Günther Sperk (ORCID: https://orcid.org/0000-0001-6561-8360)
- Xavier Ekolle Ndode‐Ekane (ORCID: https://orcid.org/0000-0001-5682-5632)
- Pierangelo Cifelli (ORCID: https://orcid.org/0000-0002-7430-7641)
- Anssi Lipponen (ORCID: https://orcid.org/0000-0002-4403-9084)
- Meinrad Drexel (ORCID: https://orcid.org/0000-0002-2705-9673)
- Noora Puhakka (ORCID: https://orcid.org/0000-0001-6151-3510)
- Alessandro Gaeta (ORCID: https://orcid.org/0000-0002-8714-4052)
- Asla Pitkänen (ORCID: https://orcid.org/0000-0002-8163-5416)
- Angela De Iacovo
- Johanna Tiilikainen
Institutions
- University of Insubria (IT)
- Innsbruck Medical University (AT)
- University of Eastern Finland (FI)
- Università degli studi di Cassino e del Lazio Meridionale (IT)
- University of L'Aquila (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Experimental Neurology
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1016/j.expneurol.2025.115183
- Citations
- 1
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.91
Funders
- Sixth Framework Programme
- Horizon 2020